There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Opko Health (OPK – Research Report) and BioNTech SE (BNTX – Research Report) with bullish sentiments.
Opko Health (OPK)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Opko Health today and set a price target of $3.00. The company’s shares closed last Thursday at $1.50.
According to TipRanks.com, Chen has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Opko Health with a $3.33 average price target, representing an 113.5% upside. In a report issued on September 21, Barrington also maintained a Buy rating on the stock with a $2.00 price target.
See today’s best-performing stocks on TipRanks >>
BioNTech SE (BNTX)
H.C. Wainwright analyst Robert Burns reiterated a Buy rating on BioNTech SE today and set a price target of $180.00. The company’s shares closed last Thursday at $102.03, close to its 52-week low of $95.50.
According to TipRanks.com, Burns has 0 stars on 0-5 stars ranking scale with an average return of
BioNTech SE has an analyst consensus of Moderate Buy, with a price target consensus of $136.67.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on OPK:
